The promise of thalidomide: Evolving indications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The promise of thalidomide: Evolving indications

Published:2004 Issue:3 Volume:40 Page:197
ISSN:0025-7656
Container-title:Drugs of Today
language:en
Short-container-title:Drugs Today

Author:

Joglekar S.,Levin M.

Publisher

Clarivate Analytics (US)

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory imide drugs inhibit human detrusor smooth muscle contraction and growth of human detrusor smooth muscle cells, and exhibit vaso-regulatory functions;Biomedicine & Pharmacotherapy;2024-08

2. Design, synthesis, anticancer evaluation, and in silico ADMET analysis of novel thalidomide analogs as promising immunomodulatory agents;RSC Advances;2023

3. Thalidomide alleviates neuropathic pain through microglial IL-10/β-endorphin signaling pathway;Biochemical Pharmacology;2021-10

4. Lenalidomide and pomalidomide inhibit growth of prostate stromal cells and human prostate smooth muscle contraction;Life Sciences;2021-09

5. Inhibition of human prostate stromal cell growth and smooth muscle contraction by thalidomide: A novel remedy in LUTS?;The Prostate;2021-03-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3